The Ministry of Health (Kemenkes) has targeted Johnson & Johnson’s Covid-19 vaccine to be used in the national vaccination program.
Referring to the Regulation of the Minister of Health (PMK) Number 18 of 2021, vaccination programs are obtained from grants, donations, or gifts from both the community and other countries. Vaccination program vaccines are provided free of charge.
“Johnson [for the vaccination] is the program,” said Spokesperson for Covid-19 Vaccinations from the Ministry of Health, Siti Nadia Tarmizi on Thursday (9/9).
Tarmizi said that the Johnson & Johnson vaccine that will be imported to Indonesia will most likely come from grants from other countries or from the Covax Facility program created by the World Health Organization (WHO).
Even so, Tarmizi cannot confirm when the vaccine will arrive in Indonesia or the number of doses that will be imported.
Health Minister Budi Gunadi Sadikin previously said that Johnson & Johnson’s Covid-19 vaccine could arrive Indonesia this month as a result of a Dutch grant.
Johnson & Johnson’s vaccine already has an emergency use authorization (EUA) from the Food and Drug Administration (BPOM).
Based on interim data from phase 3 clinical trials, 28 days after vaccination, the Johnson & Johnson vaccine provided 67.2% efficacy in preventing all symptoms of Covid-19.
The vaccine’s efficacy for preventing moderate to severe Covid-19 symptoms in subjects over 18 years of age was 66.1%.
BPOM assessed that the side effects or Post Immunization Adverse Events (AEFI) from the Johnson & Johnson Covid-19 vaccine were still within normal limits, with mild to moderate symptoms reported.
“From the results of the studies that have been carried out, it shows that in terms of safety, in general the administration of the two vaccines can be tolerated well,” said spokesperson Penny, quoted from the BPOM website on Wednesday (8/9).
Common local AEFIs include pain, redness, and swelling. Cmmon systemic AEFIs include headache, fatigue, muscle pain (myalgia), drowsiness, nausea, vomiting, fever (pyrexia) and diarrhea.